Clinical Trial: Study to Look at the Effects of ART-123 on Patients With Sepsis and Disseminated Intravascular Coagulation (DIC)

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 2B Study ot Assess the Safety and Efficacy Effects of ART-123 on Subjects With Sepsis and Disseminated Intravascular Coagulat

Brief Summary: To evaluate the safety and activity of ART-123 in reducing death in subjects with sepsis and disseminated intravascular coagulation.

Detailed Summary:
Sponsor: University of South Alabama

Current Primary Outcome: all cause mortality rate [ Time Frame: 28days ]

Original Primary Outcome: Evaluate safety and efficacy of ART-123 in reducing mortality in DIC subjects due to sepsis

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of South Alabama

Dates:
Date Received: March 17, 2010
Date Started: March 2008
Date Completion:
Last Updated: January 23, 2013
Last Verified: January 2013